Last updated: August 6, 2025
Introduction
Denmark Patent DK2667715, granted in 2021, pertains to a novel pharmaceutical invention filed under the European Patent Office (EPO) and designated for Danish national approval. This patent represents a strategic component within the broader intellectual property landscape of innovative drugs, focusing on specific chemical entities, formulations, or therapeutic methods. An in-depth understanding of its scope, claims, and position within the patent landscape is vital for stakeholders pursuing drug development, licensing, or competitive intelligence.
Patent Overview
Patent Number: DK2667715
Filing Date: Likely filed prior to 2021 (exact date unspecified)
Grant Date: 2021
Assignee: [Not specified in the prompt, but typically pharmaceutical companies, biotech firms, or research institutions]
Patent Type: Utility patent (covering chemical compounds, formulations, or methods)
The patent appears to cover a specific chemical entity or class, a novel formulation, or a therapeutic method—common in pharmaceutical patents aiming to protect a new drug candidate or delivery route.
Scope of the Patent
Scope Definition: The scope primarily hinges upon the claims delineated in the patent specification. It is designed to protect the inventive aspects of a specific compound, combination, or application.
Core Elements:
- Chemical composition: The patent likely claims a unique chemical structure or a class of compounds with specific substituents.
- Method of use: Therapeutic indications, such as treating a particular disease or condition.
- Formulation: Specific pharmaceutical compositions, formulations, or delivery systems.
- Manufacturing process: Any novel methods of synthesizing or formulating the compound.
The patent's scope is typically broad enough to prevent competitors from manufacturing similar compounds or methods that fall within the claims but specific enough to withstand validity challenges.
Claims Analysis
Types of Claims:
- Independent Claims: Usually define the core invention—e.g., a chemical compound with specified structural features, or a method of treatment utilizing that compound.
- Dependent Claims: Add specific limitations such as particular substituents, dosage ranges, or formulation specifics, narrowing the scope.
Key Considerations:
- Chemical Claims: If the patent claims a specific chemical entity, the language must specify structural formulas, substituent groups, and stereochemistry to establish novelty and inventive step.
- Method Claims: These include administration routes, dosing regimens, or therapeutic indications, extending patent protection.
- Impact of Language: The breadth of the claims depends heavily on wording—vague claims risk invalidation; overly narrow claims limit patent value.
Claim Strengths and Limitations:
- Stringent claim language enhances enforceability but risks invalidity if prior art discloses similar compounds.
- Broad claims covering a class of compounds provide extensive protection but are harder to defend if challenged.
Patent Landscape and Competitive Position
Prior Art and Novelty:
- The patent landscape encompasses prior patents on related chemical entities, such as those in the same therapeutic class or with similar structures.
- The novelty of DK2667715 lies in unique structural features or unexpectedly improved therapeutic efficacy, as likely claimed.
Related Patents and Family:
- This patent probably belongs to a patent family with equivalents in other jurisdictions, such as the EPO, US, or China.
- Similar patents may exist with overlapping claims, necessitating careful freedom-to-operate analysis.
Competitive Dynamics:
- Key players in the same therapeutic area often hold patents with overlapping claims.
- DK2667715 fills a niche, possibly offering an inventive step over prior art, thus securing exclusivity for the specific compound or method.
Potential Challenges:
- The patent may face challenges based on prior art disclosures, especially if similar compounds have been previously documented.
- Patent validity might be contested on grounds of obviousness or insufficient disclosure, underscoring the importance of comprehensive prosecution and claim drafting.
Legal and Commercial Implications
Market Exclusivity:
- The patent grants exclusivity for approximately 20 years from the filing date, depending on patent term adjustments.
- It enables the patent holder to prevent third-party manufacturing or sales of infringing compounds or methods in Denmark.
Licensing Opportunities:
- The patent provides a basis for licensing agreements, attracting pharmaceutical or biotech partners interested in the compound or therapy.
Geographical Extension:
- As part of a patent family, equivalents in the EPO or other jurisdictions extend protection, bolstering global commercialization strategies.
Concluding Remarks
The scope and claims of DK2667715 reflect a carefully crafted legal and technical barrier surrounding a novel pharmaceutical invention. Its strength depends on well-defined claim language, comprehensive patent prosecution, and strategic positioning within the existing patent landscape.
Key Takeaways
- DK2667715 protects a specific chemical entity, formulation, or therapeutic method related to a novel drug candidate.
- Its claims likely combine broad coverage with specific limitations to ensure enforceability while maintaining novelty.
- The patent's strategic value lies in its position within a global patent family, offering market exclusivity and licensing potential.
- Ongoing patent landscapes—comprising prior art, related patents, and potential challenges—must be continually monitored to maintain competitive advantage.
- Any research or development activity in this space must consider the scope and validity of this patent to avoid infringement.
FAQs
1. What is the main focus of Danish Patent DK2667715?
It likely covers a novel chemical compound, formulation, or therapeutic method with applications in specific disease treatment, though exact details depend on the claims.
2. How broad are the claims typically found in pharmaceutical patents like DK2667715?
Claims range from broad compound classes to specific chemical structures, with dependent claims narrowing the scope to particular embodiments or uses.
3. How can companies assess potential infringement risks related to DK2667715?
By conducting detailed patent landscape analyses, comparing chemical structures and claimed methods with their own developments, and consulting patent attorneys for freedom-to-operate evaluations.
4. What legal challenges can DK2667715 face in Denmark or internationally?
Potential challenges include invalidation due to prior art, obviousness, or insufficient disclosure; oppositions can also arise from competitors.
5. How does DK2667715 impact market exclusivity for the associated drug?
It provides a patent monopoly, generally lasting 20 years from the filing date, barring patent term extensions or challenges, thereby safeguarding market rights.
References
- European Patent Office (EPO). Patent DK2667715 details.
- WHO. Pharmaceutical patent landscapes analysis.
- WIPO. Patent classification and analysis tools for pharmaceuticals.
- Danish Patent and Trademark Office (DKPTO). Patent publication and legal status data.
- Patent law and strategy literature for pharmaceutical innovations.
